People who have high cholesterol may understand they need to manage their condition, but many aren’t sure how to do that, nor do they feel confident they can, according to a new survey from the American Heart Association.
The ‘facts’ that most women and clinicians consider in making the decision to use, or not use, HRT are frequently wrong or incorrectly applied says Professor Robert D Langer in a paper entitled The evidence base for HRT: what can we believe?, which will be published in the forthcoming April edition of the journal of the International Menopause Society, Climacteric. It raises serious questions about the ‘facts’ that have led women and their doctors to believe hormone therapy (often called HRT) is unsafe.
Researchers advise avoiding diclofenac and limiting ibuprofen to 1200 mg per day
Omega-3 fish oil supplements prescribed by a healthcare provider may help prevent death from heart disease in patients who recently had a heart attack and may prevent death and hospitalizations in patients with heart failure, but there is a lack of scientific research to support clinical use of these supplements to prevent heart disease in the general population, according to a new science advisory from the American Heart Association.
Only one in five patients seeking specialty care for resistant hypertension are taking all their prescribed medications, according to new research in the American Heart Association’s journal Hypertension.
“Another twenty percent are not taking any of their blood pressure medications,” said Peter Blankestijn, M.D., Ph.D., senior author of the study and professor of nephrology and hypertension at the University Medical Center Utrecht in the Netherlands. “People mistakenly thought to have resistant hypertension – which is high blood pressure despite taking three or more medications – end up seeing specialists and undergoing extra tests because we don’t understand why they are so difficult to treat.”
Statin side effects are the strongest predictor of failure to meet low-density lipoprotein (LDL) cholesterol targets, according to research published in the European Journal of Preventive Cardiology.Other predictors were statin non-adherence and use of weaker statins.